Showing results (211-220 of 523) with videos related to

Sort By:
Pageof 53
Cancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.
Pathology, Research and Practice|May 31, 2017
EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathologyVincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.
Oncotarget|March 14, 2019
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Oncology (Williston Park, N.Y.)|January 20, 2005
The promise of pharmacogenomics: gemcitabine and pemetrexedRafael Rosell, Miquel Taron, Jose Miguel Sanchez, et al.
Onkologie|June 19, 2013
Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trialsAntonin Levy, Carlos Gomez-Roca, Christophe Massard, et al.
Oncotarget|January 17, 2019
EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.
Clinical Pharmacology and Therapeutics|February 23, 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in CancerArthur Géraud, David Combarel, Christian Funck-Brentano, et al.
Lung Cancer (Amsterdam, Netherlands)|May 11, 2026
Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC surveyAna Ortega-Franco, Ilias Houda, Mariana Brandão, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2026
Evaluating health-related quality of life questionnaires in capturing common symptomatic adverse events in non-small cell lung cancerLotte van der Weijst, Cecilia Pompili, Maria Teixeira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.
Pageof 53